Antengene Corporation

Antengene Corporation

Antengene Corporation

Antengene is a biopharmaceutical company.
Founded
2016
Raised
$141M
Follow us
Featured on
Alexa global traffic share
Latest funding
$120,000,000
Venture capital (Series B) - 2019
Celgene QiMing Venture Partners Boyu Capital +3
$21,000,000
Venture capital (Series A) - 2017
QiMing Venture Partners HgCapital TF Capital
Team Size
1–10
Employees
Location
Headquarters
$120,000,000 Venture capital (Series B)
AVCJ , PE HUB , AVCJ

China’s Antengene raises $120m Series B round

ChinaMoneyNetwork

Boyu Capital Leads $120M Series B Round Into Oncology Medicine Developer Antengene